← Leaderboards
Hui Li
University Of Virginia
$8,132,942
Attributed
$8,132,942
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,132,942 · 5
By mechanism
R01$8,132,942 · 5
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsTherapeutic TargetBiological MarkersProteinsSamplingGene FusionGenesTranscriptCancer TypeRna SplicingAnimal ModelEventChimera OrganismOverexpressionCell LineNovel Therapeutic InterventionTranscriptome SequencingInvestigationBaseCodeIn VivoMouse ModelAnimals
Grant awards (24)
Targeting AVIL, a novel oncogene in rhabdomyosarcoma$503,649
R01 · FY2025 · CA · contact PI
Targeting AVIL, a novel oncogene in rhabdomyosarcoma$478,467
R01 · FY2024 · CA · contact PI
Targeting AVIL in Glioblastoma$471,746
R01 · FY2024 · CA · contact PI
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer$195,618
R01 · FY2024 · CA · contact PI
Targeting AVIL, a novel oncogene in rhabdomyosarcoma$496,947
R01 · FY2023 · CA · contact PI
Targeting AVIL in Glioblastoma$486,645
R01 · FY2023 · CA · contact PI
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer$201,794
R01 · FY2023 · CA · contact PI
Targeting AVIL in Glioblastoma$486,645
R01 · FY2022 · CA · contact PI
Genome-wide Investigation of cis-splicing between Adjacent Genes$323,000
R01 · FY2022 · GM · contact PI
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer$201,794
R01 · FY2022 · CA · contact PI
Genome-wide Investigation of cis-splicing between Adjacent Genes NOSI Admin Supplement$118,613
R01 · FY2022 · GM · contact PI
Targeting AVIL in Glioblastoma$496,575
R01 · FY2021 · CA · contact PI
Genome-wide Investigation of cis-splicing between Adjacent Genes$323,000
R01 · FY2021 · GM · contact PI
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer$205,913
R01 · FY2021 · CA · contact PI
Targeting AVIL in Glioblastoma$489,873
R01 · FY2020 · CA · contact PI
Genome-wide Investigation of cis-splicing between Adjacent Genes$323,000
R01 · FY2020 · GM · contact PI
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer$205,913
R01 · FY2020 · CA · contact PI
Genome-wide Investigation of cis-splicing between Adjacent Genes$323,000
R01 · FY2019 · GM · contact PI
cis-splicing of adjacent genes in prostate cancer$327,850
R01 · FY2018 · CA · contact PI
Induction of Gene Fusions by Pre-Existing Chimeric Transcripts$161,500
R01 · FY2018 · CA · contact PI
cis-splicing of adjacent genes in prostate cancer$327,850
R01 · FY2017 · CA · contact PI
cis-splicing of adjacent genes in prostate cancer$327,850
R01 · FY2016 · CA · contact PI
cis-splicing of adjacent genes in prostate cancer$327,850
R01 · FY2015 · CA · contact PI
cis-splicing of adjacent genes in prostate cancer$327,850
R01 · FY2014 · CA · contact PI